Clinical Trial Results
Two participants (3.6%) who got MEDI9929 and 3 participants (5.5%) who got the
placebo had serious medical problems in this study. The only serious medical problem
that happened in more than 1 participant, no matter which treatment they got, was a
serious worsening of AD, as shown in the table below.
The table below shows the serious medical problems that happened in this study.
MEDI9929 Placebo
Serious medical problem (Out of 56 participants) (Out of 55 participants)
Worsening of AD 1 (1.8%) 1 (1.8%)
Infected bump under the skin 1 (1.8%) 0 (0.0%)
Bacterial skin infection 0 (0.0%) 1 (1.8%)
Chest pain 0 (0.0%) 1 (1.8%)
Fainting 0 (0.0%) 1 (1.8%)
What were the most common non-serious medical problems in the study?
The common cold was the most common non-serious medical problem in either
treatment group. The table below shows the most common non-serious medical
problems that occurred in at least 5% of participants in this study.
MEDI9929 Placebo
Non-serious medical problem (Out of 56 participants) (Out of 55 participants)
Common cold 13 (23.2%) 11 (20.0%)
Worsening of AD 6 (10.7%) 7 (12.7%)
Diarrhea 5 (8.9%) 3 (5.5%)
Headache 3 (5.4%) 1 (1.8%)
Redness of the skin at the injection site 3 (5.4%) 0 (0.0%)
Infection of nose, throat, and/or sinus 1 (1.8%) 7 (12.7%)
Bacterial skin infection 0 (0.0%) 3 (5.5%)
7